Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Southampton
Gustave Roussy, Cancer Campus, Grand Paris